title: Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons.
abstract: An obstacle to stem cell gene therapy for AIDS is the limited numbers of hematopoietic progenitors available. Granulocyte colony-stimulating factor (G-CSF) is used for mobilization of progenitors, but little is known about the functional characteristics of mobilized progenitors, and immature and T cell progenitors may not be mobilized. This study examined the effect of G-CSF on the function of progenitors. Ten human immunodeficiency virus-infected patients received G-CSF (filgrastim, 300 microgram/day) for 5 days. Absolute numbers of immature and T cell progenitors did not increase. The ability of CD34+ progenitor cells to generate lymphocytes was examined by use of thymic organ cultures. The mean number of lymphocytes generated per CD34+ cell on day 0 was 0.72 and on day 4 was 0.09 (P<.003). The number of CD4+ cells generated per CD34+ cell was significantly reduced after G-CSF treatment. Thus, G-CSF increased the number of mature progenitor cells but did not increase T cell progenitors.
authors.affiliation: Laboratory for Infectious Diseases, 144, Hvidovre Hospital, 2650 Hvidovre, Denmark. sdn@dadlnet.dk
authors.forename: S D
authors.initials: SD
authors.lastname: Nielsen
authors.forename: D R
authors.initials: DR
authors.lastname: Clark
authors.forename: M
authors.initials: M
authors.lastname: Hutchings
authors.forename: S
authors.initials: S
authors.lastname: Dam-Larsen
authors.forename: S
authors.initials: S
authors.lastname: Repping
authors.forename: J O
authors.initials: JO
authors.lastname: Nielsen
authors.forename: L
authors.initials: L
authors.lastname: Mathiesen
authors.forename: F
authors.initials: F
authors.lastname: Miedema
authors.forename: J E
authors.initials: JE
authors.lastname: Hansen
mesh_terms: D000818:Animals; D018952:Antigens, CD34 / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D000069585:Filgrastim; D005434:Flow Cytometry; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology*; D015497:HIV-1; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009924:Organ Culture Techniques; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000502:physiology*; D013950:Thymus Gland / Q000276:immunology
chemical_list: D018952:Antigens, CD34; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim